Serum Institute partnered Oxford vaccine, Bharat Biotech Covaxin get DCGI approval for emergency use
Oxford Institute vaccine Covishield which is being developed by Pune based Serum Institute and Bharat Biotech's Covaxin has been approved by Drug Controller General of India (DCGI) on Sunday for emergency use for immunisation against Covid-19.
